Internal Medicine, Endocrinology, Diabetes, & Metabolism · Lakewood, NJ
NPI
1508838434
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1255 Route 70 Ste 31s
Lakewood, NJ, 08701
Phone (732) 908-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$468K
6,245 services
Medicare patients, 2024
1,182
Average age 74
Drug cost, 2024
$8.1M
12,975 prescriptions
Company payments, 2025
$15K
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald B Villanueva was code 99215 (office e&m - established), 1,820 times for 730 patients. In total Ronald B Villanueva billed 6,245 services in 15 codes, and Medicare paid $468K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 1,820 | 730 | $154.85 | $282K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,706 | 981 | $14.20 | $24K |
| 95251 Test - Miscellaneous | Office | 952 | 403 | $30.25 | $29K |
| 99214 Office E&M - Established | Office | 590 | 397 | $104.39 | $62K |
| 82962 Clinical Chemistry | Office | 563 | 425 | $3.21 | $1,807 |
| 99443 Telephone Services | Office | 203 | 147 | $111.34 | $23K |
| 99204 Office E&M - New | Office | 139 | 139 | $138.42 | $19K |
| 95250 Test - Miscellaneous | Office | 110 | 108 | $132.80 | $15K |
| 99203 Office E&M - New | Office | 59 | 59 | $89.70 | $5,292 |
| 95249 Test - Miscellaneous | Office | 49 | 49 | $59.55 | $2,918 |
| 99205 Office E&M - New | Office | 15 | 15 | $188.76 | $2,831 |
| 99442 Telephone Services | Office | 12 | 11 | $61.69 | $740 |
By year: 2022 $396K for 5,186 services; 2023 $368K for 4,868 services; 2024 $468K for 6,245 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 563 | 425 | $3.21 | $1,807 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald B Villanueva prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,628 prescriptions and refills. In total Ronald B Villanueva wrote 12,975 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,628 | 4,573 | 411 | $20K |
| Ozempic Semaglutide | 1,154 | 2,471 | 292 | $2.3M |
| Metformin Hcl Generic | 885 | 2,544 | 268 | $9,548 |
| Farxiga Dapagliflozin Propanediol | 615 | 1,397 | 153 | $750K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 605 | 1,671 | 257 | $74K |
| Synthroid Levothyroxine Sodium | 600 | 1,697 | 154 | $58K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 519 | 1,337 | 168 | $719K |
| Metformin Hcl Er Metformin Hcl | 473 | 1,310 | 140 | $7,155 |
| Jardiance Empagliflozin | 336 | 736 | 85 | $407K |
| Glimepiride Generic | 335 | 971 | 95 | $4,686 |
| Mounjaro Tirzepatide | 281 | 502 | 76 | $520K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 252 | 705 | 94 | $45K |
| Rosuvastatin Calcium Generic | 205 | 596 | 66 | $3,800 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 198 | 516 | 65 | $145K |
| Tresiba Flextouch U-100 Insulin Degludec | 194 | 571 | 74 | $167K |
Brand drugs: 6,839 claims; generic drugs: 4,989 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald B Villanueva $15K ($15K in general payments such as food, travel and fees) from 35 companies. The largest payer was Lilly USA, LLC with $9,831.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 30 | $9,831 |
| Novo Nordisk Inc NVO | 41 | $685 |
| Corcept Therapeutics CORT | 29 | $479 |
| Amneal Pharmaceuticals LLC AMRX | 20 | $385 |
| Dexcom, Inc. DXCM | 14 | $380 |
| Chiesi USA, Inc. | 3 | $348 |
| Amgen Inc. AMGN | 20 | $256 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $225 |
| Tandem Diabetes Care, Inc. TNDM | 8 | $215 |
| Insulet Corporation PODD | 10 | $165 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.